A blog bringing you perspectives from the frontlines of the drug pricing debate.
Anyone following the U.S. drug pricing debate knows that “drug prices” are complicated. Most brand-name prescription drugs sold…
Today, millions of Americans are staying home during the threat of COVID-19. Access to affordable prescription drugs remains…
Three months into 2020 and the prescription drug pricing crisis continues to grow; in January alone, drug manufacturers…
With the Iowa caucuses and New Hampshire primary taking the spotlight, national attention on the presidential race and…
Published in Morning Consult With the United States in a debate on high drug prices, solutions are being…
By Debra Barrett, Coalition for Affordable Prescription Drugs, James Gelfand, ERIC and Andrew MacPherson, Public Sector HealthCare Roundtable…
U.S. patients, payors and the health care system are spending billions of dollars more on prescription drugs than…
As policymakers seek to address widespread concern about high drug prices, the conversation often includes a call for…
The challenge of high and rising drug prices affects almost all Americans – and voters are unified in…
Read full op-ed in The Hill The last few weeks have seen a flurry of activity with several…
